Natural Product: NPC602752

Natural Product IDNPC602752
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
HABHUTWTLGRDDU-UHFFFAOYSA-N
IUPAC Name n.a.
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL185075
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey HABHUTWTLGRDDU-UHFFFAOYSA-N
Standard InCHI InChI=1S/C7H10O5/c8-5(7(11)12)3-1-2-4-6(9)10/h1-4H2,(H,9,10)(H,11,12)
SMILES O=C(O)CCCCC(=O)C(=O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   174.05 Volume:   165.67
?
Van der Waals volume.
Dense:   1.051 LogP:   0.364
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   0.842
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -0.819
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   6.0 Rigid Bonds:   3.0
TPSA:   91.67
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   2.0 Rings:   0.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.446 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.015 Fsp3:   0.571
MCE-18:   0.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.015 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.012
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.001
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.997 Promiscuous compounds:   0.273

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.97 MDCK Permeability:   -4.767
Pgp-inhibitor:   0.0 Pgp-substrate:   0.005
PAMPA:   0.999
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.153
20% Bioavailability (F20%):   0.086 30% Bioavailability (F30%):   0.208
50% Bioavailability (F50%):   0.151

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.012 MRP1:   0.935
Plasma Protein Binding (PPB):   42.505% Volume Distribution (VD):   -0.519
Fu: 52.852%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.842
OATP1B3 inhibitor:   0.996 BCRP inhibitor:   0.001
BSEP inhibitor:   0.048

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.788 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.007 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.0
HLM stability:   0.0
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.086 Half-life (T1/2):  1.368

ADMET: Toxicity

hERG Blockers:  0.009 hERG Blockers (10um):  0.018
Human Hepatotoxicity (H-HT):  0.417 Drug-induced Liver Injury (DILI):  0.524
AMES Toxicity:  0.172 Rat Oral Acute Toxicity:  0.179
Maximum Recommended Daily Dose:  0.087 Skin Sensitization:  0.379
Carcinogencity:  0.305 Eye Corrosion:  0.926
Eye Irritation:  0.993 Respiratory Toxicity:  0.54
Drug-induced Neurotoxicity:  0.093 Ototoxicity:  0.602
Hematotoxicity:  0.523 Drug-induced Nephrotoxicity:  0.598
Genotoxicity:  0.3 RPMI-8226 Immunitoxicity:  0.016
A549 Cytotoxicity:  0.0 Hek293 Cytotoxicity:  0.003
BCF:   0.226
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.448
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   3.406
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.279
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO60778 Methanococcus voltae Species Methanococcaceae Archaea n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3991 Individual protein Dihydrodipicolinate synthase-like, mitochondrial Homo sapiens Ki = 170000.0 nM PMID[18077163]
NPT3993 Individual protein Dihydrodipicolinate synthase Mycobacterium tuberculosis IC50 = 21000.0 nM DOI[10.1039/C9MD00107G]
NPT4435 Individual protein Dihydrodipicolinate synthase Escherichia coli K-12 Ki = 170000.0 nM PMID[15686899]
NPT4435 Individual protein Dihydrodipicolinate synthase Escherichia coli K-12 Ki = 170000.0 nM DOI[10.1039/C9MD00107G]
NPT3993 Individual protein Dihydrodipicolinate synthase Mycobacterium tuberculosis Ki = 33000.0 nM DOI[10.1039/C9MD00107G]
NPT4435 Individual protein Dihydrodipicolinate synthase Escherichia coli K-12 Ki = 170000.0 nM PMID[18977662]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT28438 Unchecked Unchecked n.a. Ki = 220000.0 nM DOI[10.1039/C9MD00107G]
NPT28438 Unchecked Unchecked n.a. Ki = 160000.0 nM DOI[10.1039/C9MD00107G]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC602752 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.625 Remote Similarity NPC134782
0.625 Remote Similarity NPC268826
0.6154 Remote Similarity NPC109026
0.6 Remote Similarity NPC214610
0.6 Remote Similarity NPC118968
0.6 Remote Similarity NPC183424
0.6 Remote Similarity NPC294085
0.5769 Remote Similarity NPC175342
0.56 Remote Similarity NPC127142
0.5556 Remote Similarity NPC155263
0.5556 Remote Similarity NPC128713
0.5417 Remote Similarity NPC18224
0.5357 Remote Similarity NPC171736
0.5357 Remote Similarity NPC301585
0.5357 Remote Similarity NPC261080
0.5357 Remote Similarity NPC132565
0.5357 Remote Similarity NPC209970
0.5357 Remote Similarity NPC216630
0.5357 Remote Similarity NPC201844
0.5357 Remote Similarity NPC301696
0.5357 Remote Similarity NPC196924
0.5357 Remote Similarity NPC307783
0.5357 Remote Similarity NPC154186
0.5357 Remote Similarity NPC149184
0.5357 Remote Similarity NPC279026
0.5357 Remote Similarity NPC113928
0.5357 Remote Similarity NPC14227
0.52 Remote Similarity NPC174368
0.5172 Remote Similarity NPC604140

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC602752 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.6 Remote Similarity NPD9655 Phase 4
0.5357 Remote Similarity NPD2270 Pre-clinical
0.5357 Remote Similarity NPD633 Phase 3
0.5357 Remote Similarity NPD9448 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data